The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of a phase II trial of first-line FOLFIRINOX for advanced gastroesophageal cancers.
 
Ramon Jin
No Relationships to Disclose
 
Haeseong Park
Research Funding - Ambrx (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Oncologie (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst); Turning Point Therapeutics (Inst); Vertex (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Bayer
 
Andrea Wang-Gillam
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Jacobio; Repugene; Tyme
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); CTI (Inst); Gossamer Bio (Inst); Hutchison MediPharma (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Newlink Genetics (Inst); pfizer (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Verastem (Inst); Xcovery (Inst)
 
Rama Suresh
No Relationships to Disclose
 
Caron E. Rigden
No Relationships to Disclose
 
Manik A. Amin
Consulting or Advisory Role - AstraZeneca (I); TERUMO (I)
 
Benjamin R. Tan
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst); Roche/Genentech (Inst); Sillajen (Inst); tyrogenex (Inst)
 
Katrina Pedersen
Consulting or Advisory Role - Array BioPharma; Bayer
Speakers' Bureau - Clinical Care Options
Research Funding - Abbvie (Inst); Merck (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Array BioPharma; BeiGene; Nouscom
 
Kian-Huat Lim
Research Funding - Aclaris Therapeutics
 
Nikolaos Trikalinos
No Relationships to Disclose
 
Abhi Acharya
No Relationships to Disclose
 
Megan Copsey
No Relationships to Disclose
 
Katie Navo
No Relationships to Disclose
 
Ashley Morton
Speakers' Bureau - Guardant Health
Other Relationship - Guardant Health
 
Feng Gao
No Relationships to Disclose
 
A. Craig Lockhart
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Sarah Cannon Research Institute (Inst)